Director Claire Koeneman at LXP Industrial Trust (NYSE: LXP) granted 664 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Koeneman Claire A reported acquisition or exercise transactions in this Form 4 filing.
LXP Industrial Trust director Claire A. Koeneman received a grant of 664 Common Shares as part of quarterly trustee fees, valued at $48.895 per share based on the average closing price over the quarter. After this award, she directly holds 26,562 Common Shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Koeneman Claire A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 664 | $48.895 | $32K |
Holdings After Transaction:
Common Shares — 26,562 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Share grant: 664 Common Shares
Grant valuation price: $48.895 per share
Total shares held after grant: 26,562 Common Shares
3 metrics
Share grant
664 Common Shares
Quarterly trustee fees to director Claire A. Koeneman
Grant valuation price
$48.895 per share
Average closing price over the quarter used for fees
Total shares held after grant
26,562 Common Shares
Direct ownership by Claire A. Koeneman following transaction
Key Terms
Quarterly trustee fees, Grant, award, or other acquisition, Common Shares
3 terms
Quarterly trustee fees financial
"Quarterly trustee fees issued at the average closing price over the quarter"
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
FAQ
What insider transaction did LXP director Claire Koeneman report on this Form 4 for LXP?
Claire A. Koeneman reported receiving 664 LXP Industrial Trust Common Shares. The shares were granted as quarterly trustee fees, not bought in the open market, and were valued at $48.895 per share based on the quarter’s average closing price.
Does the LXP Form 4 for Claire Koeneman include any derivative securities activity?
The Form 4 shows no derivative securities activity for Claire A. Koeneman. The filing only reports a non-derivative acquisition of 664 Common Shares as quarterly trustee fees, with the derivativeSummary section containing no remaining options or similar instruments.